EP Patent

EP1819673A2 — Indole derivatives for use as ppar active compounds

Assigned to Plexxikon Inc · Expires 2007-08-22 · 19y expired

What this patent protects

Compounds are described that are active on at least one of PPARα, PPARδ, and PPARϜ, which are useful for therapeutic and /or prophylactic methods involving modulation of at least one of PPARα, PPARδ, and PPARϜ.

USPTO Abstract

Compounds are described that are active on at least one of PPARα, PPARδ, and PPARϜ, which are useful for therapeutic and /or prophylactic methods involving modulation of at least one of PPARα, PPARδ, and PPARϜ.

Drugs covered by this patent

Patent Metadata

Patent number
EP1819673A2
Jurisdiction
EP
Classification
—
Expires
2007-08-22
Drug substance claim
No
Drug product claim
No
Assignee
Plexxikon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.